BRAF V600E mutation in thyroid carcinoma: a large-scale study in Han Chinese population.

doi:10.1186/s12957-024-03539-7

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

BRAF V600E mutation in thyroid carcinoma: a large-scale study in Han Chinese population.

World journal of surgical oncology - 28 Sept 2024

Cong Rong, Ouyang Hui, Zhou Di, Li Xinying, Xia Fada

Abstract excerpt

BACKGROUND: The prevalence of genetic mutations in thyroid cancer varies significantly among different ethnic backgrounds. The present study aimed to investigate the clinical potential of BRAF V600E in a large group of homogenous Han Chinese patients. METHODS: From 2018 to 2021, 6232 thyroid disease patients who underwent thyroidectomy at our hospital were enrolled. We measured the diagnostic value of BRAF and...

Topics

Adult
Aged
Female
Humans
Male
Middle Aged
Biomarkers, Tumor
China
East Asian People
Follow-Up Studies
Mutation
Neoplasm Recurrence, Local
Prognosis
Proto-Oncogene Proteins B-raf
Retrospective Studies
Survival Rate
Thyroid Cancer, Papillary
Thyroid Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 39342349
DOI: 10.1186/s12957-024-03539-7
PMCID: PMC11439211

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics